Settled!?
25/06/20 -"Bayer’s management will take a lot of money off its hands trying to settle three litigations in the US, of which the RoundUp one will be the most expensive. With this move, Bayer lifts some ..."
Pages
72
Language
English
Published on
25/06/20
You may also be interested by these reports :
18/11/26
Leaving aside the mid-term profitability outlook downgrade in 2024, Lundbeck has often exceeded expectations with its operational delivery in the ...
17/11/26
In the last couple of years, most of Roche’s peers – including Novartis, AstraZeneca, Novo Nordisk and Sanofi – have suffered important R&D setbacks, ...
17/11/26
The factors discussed in the justification for DCF valuation have also prompted an upgrade to our NAV valuation. As a result, the target price resets ...
12/11/26
The Q3 results exceeded consensus estimates, backed by the strong showing of Electronics (driven by demand from AI applications) and healthy support ...